I also think the FDA approval is not a game changer (since the so called " Bronchitol business restructure" did not happen) for the share price, unless Chiesi can do a magical sale figure in US market.
There is a chance, although remote, that the LOXL2 deal can be announced. But 2+ years already since Gary Philips bragging the drug has drawn huge interests from big pharams, I doubt this is going to happen at all.
Bone cancer is a new, cool and fancy story, which I guess will last a year or two for these guys enjoying the shareholders' money for their salary and bonus,
Show the deal and show the money Gary, or you are nothing but a liar.
Ann: Change in substantial holding, page-32
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $54.92M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.2¢ | 4.0¢ | $89.87K | 2.189M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 312221 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 500000 | 1 |
View Market Depth
| Last trade - 12.13pm 09/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |